MitraClip
Device
Abbott Laboratories
Total Payments
$1.7M
Transactions
617
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $15,850 | 6 | 5 |
| 2020 | $1.7M | 611 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.7M | 611 | 99.1% |
| Consulting Fee | $15,850 | 6 | 0.9% |
Payments by Type
Research
$1.7M
611 transactions
General
$15,850
6 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MitraClip EXPAND G4 Study | Abbott Laboratories | $356,628 | 0 |
| A substudy of the May Clinic MAC Working Group | Abbott Laboratories | $299,663 | 0 |
| Percutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Candidates for Surgery (REPAIR MR) | Abbott Laboratories | $245,545 | 0 |
| A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip Devices | Abbott Laboratories | $223,205 | 0 |
| Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) | Abbott Laboratories | $219,020 | 0 |
| Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional MR (COAPT) Continued Access Study | Abbott Laboratories | $211,302 | 0 |
| Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation | Abbott Laboratories | $133,687 | 0 |
| MANUSCRIPTS MITRACLIP AVAILABILITY | Abbott Laboratories | $15,000 | 0 |
| Trifecta GT (Glide Technology) Post Market Clinical Follow-up (PMCF) | Abbott Laboratories | $13,644 | 0 |
Top Doctors Receiving Payments for MitraClip
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Aurora, CO | $1.7M | 611 |
| , MD | Interventional Cardiology | Houston, TX | $12,750 | 2 |
| , MD | Clinical Cardiac Electrophysiology | New York, NY | $1,500 | 1 |
| , M.D | Interventional Cardiology | Minneapolis, MN | $600.00 | 1 |
| , M.D | Cardiovascular Disease | Sacramento, CA | $500.00 | 1 |
| , M.D | Cardiovascular Disease | Sacramento, CA | $500.00 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $1.7M
Product Information
- Type Device
- Total Payments $1.7M
- Total Doctors 5
- Transactions 617
About MitraClip
MitraClip is a device associated with $1.7M in payments to 5 healthcare providers, recorded across 617 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2021. In 2021, $15,850 was paid across 6 transactions to 5 doctors.
The most common payment nature for MitraClip is "Unspecified" ($1.7M, 99.1% of total).
MitraClip is associated with 9 research studies, including "MitraClip EXPAND G4 Study" ($356,628).